230 related articles for article (PubMed ID: 25666192)
1. Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.
Villa E; Critelli R; Lei B; Marzocchi G; Cammà C; Giannelli G; Pontisso P; Cabibbo G; Enea M; Colopi S; Caporali C; Pollicino T; Milosa F; Karampatou A; Todesca P; Bertolini E; Maccio L; Martinez-Chantar ML; Turola E; Del Buono M; De Maria N; Ballestri S; Schepis F; Loria P; Enrico Gerunda G; Losi L; Cillo U
Gut; 2016 May; 65(5):861-9. PubMed ID: 25666192
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of total hepatocellular cancer lifespan, including both clinically evident and preclinical development, using combined network phenotyping strategy and fisher information analysis.
Pančoška P; Skála L; Nešetřil J; Carr BI
Semin Oncol; 2015 Apr; 42(2):339-46. PubMed ID: 25843738
[TBL] [Abstract][Full Text] [Related]
3. Indolent cancer and pattern of progression: Two missing parameters in trial design for hepatology.
Iavarone M; Nault JC; Cabibbo G; Torres F; Reig M
Hepatology; 2024 Jun; 79(6):1452-1462. PubMed ID: 37399245
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular Carcinoma with β-Catenin Mutation: Imaging and Pathologic Characteristics.
Kitao A; Matsui O; Yoneda N; Kozaka K; Kobayashi S; Sanada J; Koda W; Minami T; Inoue D; Yoshida K; Yamashita T; Yamashita T; Kaneko S; Takamura H; Ohta T; Ikeda H; Nakanuma Y; Kita R; Gabata T
Radiology; 2015 Jun; 275(3):708-17. PubMed ID: 25668519
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic markers in plasma cell myeloma patients treated with novel agents.
Medinger M; Halter J; Heim D; Buser A; Gerull S; Stern M; Passweg J
Anticancer Res; 2015 Feb; 35(2):1085-90. PubMed ID: 25667497
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis of biopsy samples reveals critical limitations of transcriptome-based molecular classifications of hepatocellular carcinoma.
Makowska Z; Boldanova T; Adametz D; Quagliata L; Vogt JE; Dill MT; Matter MS; Roth V; Terracciano L; Heim MH
J Pathol Clin Res; 2016 Apr; 2(2):80-92. PubMed ID: 27499918
[TBL] [Abstract][Full Text] [Related]
7. SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer.
Zubiete-Franco I; García-Rodríguez JL; Lopitz-Otsoa F; Serrano-Macia M; Simon J; Fernández-Tussy P; Barbier-Torres L; Fernández-Ramos D; Gutiérrez-de-Juan V; López de Davalillo S; Carlevaris O; Beguiristain Gómez A; Villa E; Calvisi D; Martín C; Berra E; Aspichueta P; Beraza N; Varela-Rey M; Ávila M; Rodríguez MS; Mato JM; Díaz-Moreno I; Díaz-Quintana A; Delgado TC; Martínez-Chantar ML
EBioMedicine; 2019 Feb; 40():406-421. PubMed ID: 30594553
[TBL] [Abstract][Full Text] [Related]
8. Making sorafenib irresistible: In vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14.
Avila M; Berasain C
Hepatology; 2015 May; 61(5):1755-7. PubMed ID: 25677471
[No Abstract] [Full Text] [Related]
9. Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study.
Wu CY; Hsu YC; Ho HJ; Chen YJ; Lee TY; Lin JT
Gut; 2016 Apr; 65(4):693-701. PubMed ID: 25670811
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
Gastroenterology; 2015 Jun; 148(7):1383-91.e6. PubMed ID: 25747273
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.
Kim HD; Lim YS; Han S; An J; Kim GA; Kim SY; Lee SJ; Won HJ; Byun JH
Gastroenterology; 2015 Jun; 148(7):1371-82. PubMed ID: 25733098
[TBL] [Abstract][Full Text] [Related]
12. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
[TBL] [Abstract][Full Text] [Related]
13. Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation.
Miltiadous O; Sia D; Hoshida Y; Fiel MI; Harrington AN; Thung SN; Tan PS; Dong H; Revill K; Chang CY; Roayaie S; Byrne TJ; Mazzaferro V; Rakela J; Florman S; Schwartz M; Llovet JM
J Hepatol; 2015 Dec; 63(6):1368-77. PubMed ID: 26220754
[TBL] [Abstract][Full Text] [Related]
14. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner.
Fang JH; Zhou HC; Zhang C; Shang LR; Zhang L; Xu J; Zheng L; Yuan Y; Guo RP; Jia WH; Yun JP; Chen MS; Zhang Y; Zhuang SM
Hepatology; 2015 Aug; 62(2):452-65. PubMed ID: 25711742
[TBL] [Abstract][Full Text] [Related]
15. PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.
Bonavita E; Gentile S; Rubino M; Maina V; Papait R; Kunderfranco P; Greco C; Feruglio F; Molgora M; Laface I; Tartari S; Doni A; Pasqualini F; Barbati E; Basso G; Galdiero MR; Nebuloni M; Roncalli M; Colombo P; Laghi L; Lambris JD; Jaillon S; Garlanda C; Mantovani A
Cell; 2015 Feb; 160(4):700-714. PubMed ID: 25679762
[TBL] [Abstract][Full Text] [Related]
16. Loss of plexin-B3 in hepatocellular carcinoma.
Liu Y; Wu C; Wang Y; Wen S; Wang J; Chen Z; He Q; Feng D
Exp Ther Med; 2015 Apr; 9(4):1247-1252. PubMed ID: 25780417
[TBL] [Abstract][Full Text] [Related]
17. CMV infection of human sinusoidal endothelium regulates hepatic T cell recruitment and activation.
Bruns T; Zimmermann HW; Pachnio A; Li KK; Trivedi PJ; Reynolds G; Hubscher S; Stamataki Z; Badenhorst PW; Weston CJ; Moss PA; Adams DH
J Hepatol; 2015 Jul; 63(1):38-49. PubMed ID: 25770658
[TBL] [Abstract][Full Text] [Related]
18. Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features.
Sia D; Jiao Y; Martinez-Quetglas I; Kuchuk O; Villacorta-Martin C; Castro de Moura M; Putra J; Camprecios G; Bassaganyas L; Akers N; Losic B; Waxman S; Thung SN; Mazzaferro V; Esteller M; Friedman SL; Schwartz M; Villanueva A; Llovet JM
Gastroenterology; 2017 Sep; 153(3):812-826. PubMed ID: 28624577
[TBL] [Abstract][Full Text] [Related]
19. Proteoglycan-4 is correlated with longer survival in HCC patients and enhances sorafenib and regorafenib effectiveness via CD44 in vitro.
Dituri F; Scialpi R; Schmidt TA; Frusciante M; Mancarella S; Lupo LG; Villa E; Giannelli G
Cell Death Dis; 2020 Nov; 11(11):984. PubMed ID: 33199679
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
